EU clears Israel’s Teva to buy Barr Pharmaceutical

BRUSSELS, Dec 19 (Reuters) – The European Commission on
Friday approved Israeli drugmaker Teva Pharmaceutical’s
planned takeover of U.S. biopharmaceutical and generic drugs
marketer Barr Pharmaceuticals Inc , subject to
conditions.

Leave a Reply